MedTrace Logo

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

NCT07220330 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2026-05-06

No results posted yet for this study

Summary

The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as remotely.

Conditions

  • No History of ADHD
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Healthy Volunteer

Interventions

DEVICE

QbMobile

QbMobile is a software application that can be installed on a smartphone device used to measure activity, attention, impulsivity, and movement patterns in participants over a two-day period.

Sponsors & Collaborators

  • Qbtech AB

    lead INDUSTRY

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07220330 on ClinicalTrials.gov